Neogene Therapeutics
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group.
Work at Neogene Therapeutics in HR or recruiting? Claim this page
Headcount trend
Neogene Therapeutics went from 94 employees in Oct 2024 to 26 in Sep 2026.
Org structure
Headcount by department
H-1B sponsorship
Peer reviews
Worked with someone at Neogene Therapeutics?
Anonymous peer reviews on OffTheRecord
Similar companies
Neogene Therapeutics FAQ
How many employees does Neogene Therapeutics have?
Neogene Therapeutics has about 26 employees, unchanged over the 3 months to Sep 2026.
Does Neogene Therapeutics sponsor H1B visas?
Yes. Neogene Therapeutics filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Executive role.
What is Neogene Therapeutics's revenue per employee?
Neogene Therapeutics makes about $77K in revenue per employee, based on $2M annual revenue and 26 employees.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.